1. Deng G, Li Y, Ma S, et al. Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress. Free Radic Biol Med 2020; 148: 151-161.
2.
Cassim S, Bilodeau M, Vincent C, et al. Novel immunotherapies for autoimmune hepatitis. Front Pediatr 2017; 26: 5-8.
3.
Sîrbe C, Badii M, Crişan TO, et al. Detection of novel biomarkers in pediatric autoimmune hepatitis by proteomic profiling. Int J Mol Sci 2023; 24: 7479.
4.
Aljumah AA, Al Jarallah B, Albenmousa A, et al. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi J Gastroenterol 2018; 24 (Suppl 1): S1-S20.
5.
Yuan X, Duan SZ, Cao J, et al. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients. Eur J Gastroenterol Hepatol 2019; 31: 1467-1474.
6.
Park SW, Um SH, Lee HA, et al. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis. Clin Mol Hepatol 2016; 22: 281-285.
7.
van Gerven NM, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013; 58: 141-147.
8.
Kalla R, Kennedy NA, Ventham NT, et al. Serum calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases. Am J Gastroenterol 2016; 111: 1796-1805.
9.
Taubert R, Hardtke-Wolenski M, Noyan F, et al. Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLoS One 2017; 12: e0179074.
10.
Bohne F, Martínez-Llordella M, Lozano JJ, et al. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368-382.
11.
Ebadi M, Bhanji RA, Mazurak VC, et al. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Aliment Pharmacol Ther 2019; 49: 173-182.
12.
Tao S, Zhang H, Zhao Q, et al. Correlation of vitamin D with inflammatory factors, oxidative stress, and T cell subsets in patients with autoimmune hepatitis. Exp Ther Med 2020; 19: 3419-3424.
13.
Hennes EM, Zeniya M, Czaja AJ, et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
14.
Pape S, Snijders RJ, Gevers TJ, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol 2022; 76: 841-849.
15.
van Gerven NM, de Boer YS, Mulder CJ, et al. Auto immune hepatitis. World J Gastroenterol 2016; 22: 4651-4661.
16.
Luong KVQ, Nguyen LT. The role of vitamin D in autoimmune hepatitis. J Clin Med Res 2013; 5: 407-415.
17.
O’Brien MA, Jackson MW. Vitamin D and the immune system: beyond rickets. Vet J 2012; 194: 27-33.
18.
Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-520.
19.
Saron ML, Godoy HT, Hessel G. Nutritional status of patients with biliary atresia and autoimmune hepatitis related to serum levels of vitamins A, D and E. Arq Gastroenterol 2009; 46: 62-68.
20.
Anderson GJ, Frazer DM. Hepatic iron metabolism. Semin Liver Dis 2005; 25: 420-432.
21.
Chen Q, Gao M, Yang H, et al. Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis. BMC Gastroenterol 2022; 22: 23.
22.
Efe C, Kav T, Aydin C, et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci 2014; 59: 3035-3042.
23.
Behairy BE, Sira MM, Zalata KR, et al. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: does etiology matter. World J Gastroenterol 2016; 22: 4238-4249.
24.
Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, et al. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C. BMC Infect Dis 2017; 17: 361.
25.
Dhole SD, Kher AS, Ghildiyal RG, et al. Chronic liver diseases in children: clinical profile and histology. J Clin Diagn Res 2015; 9: SC04.
26.
Vitfell-Pedersen J, Jørgensen MH, Müller K, et al. Autoimmune hepatitis in children in Eastern Denmark. J Pediatr Gastroenterol Nutr 2012; 55: 376-379.
27.
Ngu JH, Gearry RB, Frampton CM, et al. Predictors of poor outcome in patients with autoimmune hepatitis: a population‐based study. Hepatology 2013; 57: 2399-2406.
28.
Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2011; 8: 320-329.
29.
Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin Infect Dis 2005; 40: 834-841.
30.
Roberts EA. Autoimmune hepatitis from the paediatric perspective. Liver Int 2011; 31: 1424-1431.